Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for prevention of maternal-fetal complications in pregnant women with chronic hypertension
2018-004160-58Phase 3Active
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Cartia and aspirin in chronic hypertension in pregnancy (CHTN) (2 arms), sponsored by Centre Hospitalier Intercommunal de Créteil. Primary endpoint: Composite maternal-fetal morbidity and mortality endpoint. Started Jul 2020; status: active.
02
Drugs
Cartiaaspirin
03
Conditions
chronic hypertension in pregnancy (CHTN)
Beyond the preview
Go deeper on 2018-004160-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004160-58.